Cargando…

Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome

Marfan syndrome (MFS) is a pleiotropic genetic disease involving the cardiovascular system where a fibrillin-1 mutation is present. This mutation is associated with accelerated activation of transforming growth factor β (TGFβ1) which contributes to the formation of aneurysms in the root of the aorta...

Descripción completa

Detalles Bibliográficos
Autores principales: Soto, María E., Guarner-Lans, Verónica, Herrera-Morales, Karla Y., Pérez-Torres, Israel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816394/
https://www.ncbi.nlm.nih.gov/pubmed/29483877
http://dx.doi.org/10.3389/fphys.2018.00077
_version_ 1783300665008717824
author Soto, María E.
Guarner-Lans, Verónica
Herrera-Morales, Karla Y.
Pérez-Torres, Israel
author_facet Soto, María E.
Guarner-Lans, Verónica
Herrera-Morales, Karla Y.
Pérez-Torres, Israel
author_sort Soto, María E.
collection PubMed
description Marfan syndrome (MFS) is a pleiotropic genetic disease involving the cardiovascular system where a fibrillin-1 mutation is present. This mutation is associated with accelerated activation of transforming growth factor β (TGFβ1) which contributes to the formation of aneurysms in the root of the aorta. There is an imbalance in the synthesis of thromboxane A(2) (TXA(2)) and prostacyclin, that is a consequence of a differential protein expression of the isoforms of cyclooxygenases (COXs), suggesting an alteration of arachidonic acid (AA) metabolism. The aim of this study was to analyze the participation of AA metabolism associated with inflammatory factors in the dilation and dissection of the aortic aneurysm in patients with MFS. A decrease in AA (p = 0.02), an increase in oleic acid (OA), TGFβ1, tumor necrosis factor alpha (TNFα), prostaglandin E(2) (PGE(2)) (p < 0.05), and COXs activity (p = 0.002) was found. The expressions of phospholipase A(2) (PLA(2)), cytochrome P450 (CYP450 4A), 5-lipoxygenase (5-LOX), COX2 and TXA2R (p < 0.05) showed a significant increase in the aortic aneurysm of patients with MFS compared to control subjects. COX1, 6-keto-prostaglandin 1 alpha (6-keto-PG(1α)) and 8-isoprostane did not show significant changes. Histological examination of the aortas showed an increase of cystic necrosis, elastic fibers and collagen in MFS. The results suggest that there are inflammatory factors coupled to genetic factors that predispose to aortic endothelial dysfunction in the aortic tissue of patients with MFS. There is a decrease in the percentage of AA, associated with an increase of PLA(2), COX2/TXA2R, CYP450 4A, and 5-LOX which leads to a greater synthesis of PGE(2) than of 6-keto-PGF(1α), thus contributing to the formation of the aortic aneurysm. The evident loss of the homeostasis in these mechanisms confirms that there is a participation of the AA pathway in the aneurysm progression in MFS.
format Online
Article
Text
id pubmed-5816394
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58163942018-02-26 Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome Soto, María E. Guarner-Lans, Verónica Herrera-Morales, Karla Y. Pérez-Torres, Israel Front Physiol Physiology Marfan syndrome (MFS) is a pleiotropic genetic disease involving the cardiovascular system where a fibrillin-1 mutation is present. This mutation is associated with accelerated activation of transforming growth factor β (TGFβ1) which contributes to the formation of aneurysms in the root of the aorta. There is an imbalance in the synthesis of thromboxane A(2) (TXA(2)) and prostacyclin, that is a consequence of a differential protein expression of the isoforms of cyclooxygenases (COXs), suggesting an alteration of arachidonic acid (AA) metabolism. The aim of this study was to analyze the participation of AA metabolism associated with inflammatory factors in the dilation and dissection of the aortic aneurysm in patients with MFS. A decrease in AA (p = 0.02), an increase in oleic acid (OA), TGFβ1, tumor necrosis factor alpha (TNFα), prostaglandin E(2) (PGE(2)) (p < 0.05), and COXs activity (p = 0.002) was found. The expressions of phospholipase A(2) (PLA(2)), cytochrome P450 (CYP450 4A), 5-lipoxygenase (5-LOX), COX2 and TXA2R (p < 0.05) showed a significant increase in the aortic aneurysm of patients with MFS compared to control subjects. COX1, 6-keto-prostaglandin 1 alpha (6-keto-PG(1α)) and 8-isoprostane did not show significant changes. Histological examination of the aortas showed an increase of cystic necrosis, elastic fibers and collagen in MFS. The results suggest that there are inflammatory factors coupled to genetic factors that predispose to aortic endothelial dysfunction in the aortic tissue of patients with MFS. There is a decrease in the percentage of AA, associated with an increase of PLA(2), COX2/TXA2R, CYP450 4A, and 5-LOX which leads to a greater synthesis of PGE(2) than of 6-keto-PGF(1α), thus contributing to the formation of the aortic aneurysm. The evident loss of the homeostasis in these mechanisms confirms that there is a participation of the AA pathway in the aneurysm progression in MFS. Frontiers Media S.A. 2018-02-12 /pmc/articles/PMC5816394/ /pubmed/29483877 http://dx.doi.org/10.3389/fphys.2018.00077 Text en Copyright © 2018 Soto, Guarner-Lans, Herrera-Morales and Pérez-Torres. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Physiology
Soto, María E.
Guarner-Lans, Verónica
Herrera-Morales, Karla Y.
Pérez-Torres, Israel
Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
title Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
title_full Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
title_fullStr Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
title_full_unstemmed Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
title_short Participation of Arachidonic Acid Metabolism in the Aortic Aneurysm Formation in Patients with Marfan Syndrome
title_sort participation of arachidonic acid metabolism in the aortic aneurysm formation in patients with marfan syndrome
topic Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5816394/
https://www.ncbi.nlm.nih.gov/pubmed/29483877
http://dx.doi.org/10.3389/fphys.2018.00077
work_keys_str_mv AT sotomariae participationofarachidonicacidmetabolismintheaorticaneurysmformationinpatientswithmarfansyndrome
AT guarnerlansveronica participationofarachidonicacidmetabolismintheaorticaneurysmformationinpatientswithmarfansyndrome
AT herreramoraleskarlay participationofarachidonicacidmetabolismintheaorticaneurysmformationinpatientswithmarfansyndrome
AT pereztorresisrael participationofarachidonicacidmetabolismintheaorticaneurysmformationinpatientswithmarfansyndrome